This release appeared last week:
$18.8 million to supercharge digital health technologies
The
Australian Government is investing $18.8 million to supercharge the discovery of
better treatments for cancer, epilepsy, stroke, paralysis, Irritable Bowel
Syndrome, brain injuries, back pain and chronic middle ear disease.
The Hon Greg Hunt MP
Minister for Health
Minister for Health
Date published: 20 July 2020
The Morrison Government is investing $18.8
million to supercharge the discovery of better treatments for cancer, epilepsy,
stroke, paralysis, Irritable Bowel Syndrome, brain injuries, back pain and
chronic middle ear disease.
Under round three of our Government’s $45
million BioMedTech Horizons (BMTH) program, 21 very promising projects will
receive funding to help unlock some of the key health challenges of our times.
Successful applicants will use the funding to
develop medical devices–including wearable devices–telehealth and telemedicine,
and digitally-enabled personalised medicine.
Our
Government is supporting Australia’s world-class biomedical and medical technology
sector for the benefit of all Australians, while creating new jobs, growing expertise
and building sustainable export markets.
Victoria-based
Seer will receive $1 million to develop a real-time seizure forecasting system,
through mobile and wearable monitoring, to empower people with epilepsy to
regain control of their condition.
This
project has great potential to save lives and improve lives of people with
epilepsy and their families.
Other
projects include a 3D bioprinting system for regenerating skin and developing a
smart brain biopsy needle for faster, safer neurosurgery.
The
Morrison Government provides funding for the BioMedTech Horizons program through
its $20 billion Medical Research Future Fund (MRFF), while industry is backing
these projects by matching contributions to the tune of $21.3 million.
The
MRFF is a key pillar of Australia’s long term national health plan to build the
world’s best health system.
MTPConnect,
a not-for-profit organisation driving innovation, productivity and competitiveness
in the medical technologies, biotechnologies and pharmaceuticals sector, delivers
BioMedTech Horizons on behalf of the Australian Government.
Further
information is available on the MRFF website.
Round three — BioMedTech Horizons program
Project
|
Recipient
|
Funding
|
Digitally enabled skullcaps to monitor brain swelling in craniectomy
patients to optimise timing of skull reconstruction surgery.
|
Anatomics Pty Ltd, Victoria
|
$997,920
|
A nano-optimised surface to prevent orthopaedic implant and dental
infections.
|
Anisop Holdings Pty Ltd, New South Wales
|
$1,000,000
|
Artificial intelligence-based clinical decision support software for
guiding acute stroke therapy.
|
Apollo Medical Imaging Technology Pty Ltd, Victoria
|
$346,500
|
Automated methods for evaluating cardiac CT angiography and high-risk imaging
biomarkers
|
Artrya Pty Ltd, Western Australia
|
$987,428
|
Application of Atmo ingestible gas sensing capsule to diagnose Irritable
Bowel Syndrome (IBS) and Small Intestinal Bacterial Overgrowth (SIBO).
|
Atmo Biosciences Pty Ltd, Victoria
|
$620,000
|
Development of an implantable vision system in the Bionic Eye Generation
3 device to restore functional vision for blind patients.
|
Bionic Vision Technologies Pty Ltd, Victoria
|
$1,000,000
|
High resolution cortical recording for the prediction and prevention of epileptic
seizures.
|
Carbon Cybernetics, Victoria
|
$1,000,000
|
ClearDrum® which is an acoustically-optimised silk fibroin membrane for
the treatment of chronic middle ear disease.
|
Ear Science Institute Australia, Western Australia
|
$993,500
|
Improving colorectal cancer outcomes with hybrid cancer tracers.
|
Ferronova Pty Ltd, South Australia
|
$826,000
|
Development of miniature, low-energy wireless power and data transmission
systems for implantable medical devices.
|
Hemideina, Victoria
|
$660,520
|
Developing a 3D bioprinting system for intraoperative skin regeneration.
|
Inventia Life Science Pty Ltd, New South Wales
|
$1,000,000
|
Augmented digital re-construction and re-visualisation of spine MRI for
the personalised diagnosis of back pain.
|
Merunova Pty Ltd, New South Wales
|
$977,000
|
A smart brain biopsy needle for faster, safer neurosurgery.
|
Miniprobes Pty Ltd, South Australia
|
$1,000,000
|
Commercialisation of hand and arm wearable for use with Neuromersiv Virtual
Reality rehabilitation system.
|
Neuromersiv Pty Ltd, New South Wales
|
$994,000
|
Advancing commercialisation of its PulseVAD pulsatile rotary blood pump
designed to treat patients suffering from a form of Congestive Heart Failure
(CHF) for which there is no effective treatment.
|
Northern Research Pty Ltd, New South Wales
|
$1,000,000
|
Compact wireless technology for improved accuracy during breast conserving
surgery.
|
OncoRes Medical Pty Ltd, Western Australia
|
$1,000,000
|
Use of non-invasive confocal endomicroscopy system to enhance oral
cancer screening and surgical margin assessment.
|
Optiscan Pty Ltd, Victoria
|
$971,000
|
Personalised epilepsy treatment via mobile and wearable monitoring.
|
Seer, Victoria
|
$1,000,000
|
Stentrode; enabling people with paralysis to restore functional independence
(email communication, text messaging and online shopping) by controlling apps
and external devices through thought alone, and without requiring open brain
surgery.
|
Synchron Australia Pty Ltd, Victoria
|
$990,000
|
Development of a transcatheter blood pump system for Cardiogenic Shock
and Hemodynamically Compromised patients.
|
VenstraMedical Pty Ltd, New South Wales
|
$850,000
|
Establishing domestic capabilities for combined
R&D and manufacture of point-of-care diagnostics.
|
Zip Diagnostics, Victoria
|
$600,000
|
*Funding amounts are subject
to contract negotiation.
Here is the link to the release:
ZDNet covered the announcement as
well.
Australian government fronts up $19 million for digital health tech development
Elsewhere, RMIT Online and the Digital Health
Cooperative Research Centre have announced a suite of digital health short
courses.
The federal government has announced it will
be handing over a total of AU$18.8 million to fund the development of 21 new
biomedical and medical technology projects.
The funding is part of round three of the
government's AU$45 million BioMedTech Horizons program, an initiative designed
to support the development of health technologies.
"Successful applicants will use the
funding to develop medical devices -- including wearable devices -- telehealth
and telemedicine, and digitally-enabled personalised medicine," Minister for
Health Greg Hunt said.
"Our government is supporting Australia's
world-class biomedical and medical technology sector for the benefit of all
Australians, while creating new jobs, growing expertise and building
sustainable export markets."
Projects
that will receive the funding include Victoria-based Seer to develop a personalised
epilepsy mobile and wearable monitoring device, New South Wales-based Inventia
Life Science, which is developing a 3D bioprinting system for skin regeneration,
and South Australia's Miniprobes for developing a smart biopsy needle for faster,
safer neurosurgery. Each of these projects will receive AU$1 million from the
handout.
Other
technology projects are focused on treatments for cancer, stroke, paralysis,
irritable bowel syndrome, brain injuries, back pain, and chronic middle ear
disease.
More here:
Seems to me it is worthwhile to be
seeding these projects with a little funding to see if they really can make a
difference! It is but a very tiny part of the overall Health Budget.
David.
No comments:
Post a Comment